Jointown Pharmaceutical Group Co (SHSE:600998) Marketable Securities: ¥509 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600998 Jointown Pharmaceutical Group Co Ltd SHSE:600998
83 GF Score
Price ¥4.92
GF Value ¥5.60
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Jointown Pharmaceutical Group Co Marketable Securities?

Jointown Pharmaceutical Group Co SHSE:600998 +0.20% 83 Marketable Securities is ¥509 Mil as of Mar. 2026. GuruFocus rates SHSE:600998 with a GF Score™ of 83/100 and a GF Value™ of ¥5.60 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Jointown Pharmaceutical Group Co's Marketable Securities for the quarter that ended in Mar. 2026 was ¥509 Mil.

Jointown Pharmaceutical Group Co's annual Marketable Securities increased from Dec. 2023 (¥90 Mil) to Dec. 2024 (¥972 Mil) but then declined from Dec. 2024 (¥972 Mil) to Dec. 2025 (¥106 Mil).

Jointown Pharmaceutical Group Co  (SHSE:600998) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Jointown Pharmaceutical Group Co Marketable Securities Related Terms

Jointown Pharmaceutical Group Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Jointown Pharmaceutical Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jointown Pharmaceutical Group Co Marketable Securities Chart

Jointown Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,597.18 319.72 90.03 972.34 105.79

Jointown Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.36 69.44 69.41 105.79 508.63
SHSE:600998
83GF Score
Jointown Pharmaceutical Group Co Ltd SHSE:600998
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jointown Pharmaceutical Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥509 Mil mean?
Jointown Pharmaceutical Group Co (SHSE:600998) has a Marketable Securities of ¥509 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jointown Pharmaceutical Group Co and its competitors.
Is Jointown Pharmaceutical Group Co's Marketable Securities too high?
Jointown Pharmaceutical Group Co's current Marketable Securities is ¥509 Mil. Overall, Jointown Pharmaceutical Group Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jointown Pharmaceutical Group Co's Marketable Securities compare to MCK and COR?
Jointown Pharmaceutical Group Co's Marketable Securities of ¥509 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Distribution company?
A good Marketable Securities depends on the Medical Distribution industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jointown Pharmaceutical Group Co and its competitors. Jointown Pharmaceutical Group Co's current Marketable Securities is ¥509 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jointown Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co (SHSE:600998) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.60, compared to a current price of ¥4.92 — trading 12.1% below its estimated fair value. The current Marketable Securities is ¥509 Mil. Jointown Pharmaceutical Group Co's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Jointown Pharmaceutical Group Co (SHSE:600998), the current Marketable Securities is ¥509 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jointown Pharmaceutical Group Co (SHSE:600998) Overvalued in 2026?

Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥4.92 is trading 12.1% below its estimated GF Value™ of ¥5.60. GuruFocus considers Jointown Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600998:

  • Marketable Securities: ¥509 Mil
  • GF Value™: ¥5.60 vs. price of ¥4.92 (12.1% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jointown Pharmaceutical Group Co Business Description

Address No. 5, Longxing West Street, Hanyang District, Hubei Province, Wuhan, CHN, 430051
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and mainly serves medical institutions, wholesale enterprises, and retail pharmacies.
83GF Score

Get the complete analysis for SHSE:600998

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.92
Price
¥5.60
GF Value